INTRODUCTION: Ribavirin is a broad-spectrum antiviral drug that is used to cure hepatitis C and other viral infections. OBJECTIVE: To demonstrate the protective effects of lutein against red blood cell membrane damage caused by ribavirin toxicity. METHODS: A quasi-experimental study was conducted at Isra University Hyderabad from October 2021-February 2022. Study animals were recruited from the animal husbandry of Sindh Agriculture University, Tando-Jam. Healthy male Albino Wistar rats of bodyweight between 200 and 250 grams were included in the study while female and unhealthy rats were excluded from the study. Animals were handled according to guidelines for handling laboratory animals provided by the national institute of health. Total of 30 rats (selected randomly) were allowed to acclimatize after which they were divided into three equal (n=10) groups. Group I, II and III. Group I (Control group): The animals received normal chow along with 0.9% normal saline as placebo drug. Group II (Ribavirin or experimental group): These animals received Ribavirin alone (4mg/Kg/day) along with normal chow. Group III (Ribavirin plus Lutein group): These animals received Ribavirin (4mg/Kg/day) with Lutein (150mg/ Kg/day) along with normal chow diet. RESULTS: There is a significant decline in the body weight of study animals in group II compared with the animals in groups I and III. There is no significant difference (p> 0.05) in body weight between the animals in all study groups. There was a significant decrease in mean RBC count, MCV, MCHC, MCH and hematocrit count in the ribavirin-treated experimental group (group II) compared with the counterparts in groups I and III. There was a statistically significant difference (p<0.05) in mean RBC count, MCHC and hematocrit count. CONCLUSION: Ribavirin leads to marked red blood cell hemolysis as evident through peripheral blood smear and RBC indices. Lutein has a protective role against ribavirin-induced hemolysis in rats.